Triflavin, an Arg-Gly-Asp-Containing peptide, inhibits B16-F10 mouse melanoma cell adhesion to matrix proteins via direct binding to tumor cells

J. R. Sheu, T. F. Huang

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Triflavin, an Arg-Gly-Asp (RGD)-containing snake venom peptide, inhibits B16-F10 mouse melanoma cell adhesion to extracellular matrices, e.g., fibronectin, vitronectin, fibrinogen, and collagen type I. In this study, GRGDS inhibits B16-F10 mouse melanoma cell adhesion to immobilized triflavin in a dose-dependent manner. In addition, flow-cytometric analysis and the fluorescence staining method in which FITC-triflavin is utilized as a binding ligand were used. GRGDS inhibits the binding of FITC-triflavin to B16-F10 cells. Additionally, the above results suggest that triflavin directly binds to its receptors expressed on B16-F10 cell surface primarily via its RGD sequence, thereby inhibiting B16-F10 cell adhesion to extracellular matrices.

Original languageEnglish
Pages (from-to)359-364
Number of pages6
JournalJournal of Biomedical Science
Volume3
Issue number5
DOIs
Publication statusPublished - 1996

Keywords

  • Extracellulr matrix
  • Melanoma cells
  • RGD-containing peptide
  • Triflavin

ASJC Scopus subject areas

  • Biochemistry, medical
  • Pharmacology (medical)
  • Molecular Biology
  • Clinical Biochemistry
  • Endocrinology, Diabetes and Metabolism
  • Cell Biology

Fingerprint

Dive into the research topics of 'Triflavin, an Arg-Gly-Asp-Containing peptide, inhibits B16-F10 mouse melanoma cell adhesion to matrix proteins via direct binding to tumor cells'. Together they form a unique fingerprint.

Cite this